Evidence map›Paper›PMID 41030447›Full record

ArticleFrontiers in immunology2025

The diverse

Sara Trzos, Marta Szewczyk, Paweł Link-Lenczowski, Grzegorz Sokołowski, Małgorzata Trofimiuk-Müldner, Katarzyna Bocian, Ewa Pocheć

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sara TrzosDepartment of Glycoconjugate Biochemistry, Institute of Zoology and Biomedical Research, Faculty of Biology, Jagiellonian University, Krakow, Poland.
Marta SzewczykDepartment of Glycoconjugate Biochemistry, Institute of Zoology and Biomedical Research, Faculty of Biology, Jagiellonian University, Krakow, Poland.
Paweł Link-LenczowskiDepartment of Medical Physiology, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland.
Grzegorz SokołowskiDepartment of Endocrinology, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland.
Małgorzata Trofimiuk-MüldnerDepartment of Endocrinology, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland.
Katarzyna BocianDepartment of Immunology, Institute of Experimental Zoology, Faculty of Biology, University of Warsaw, Warsaw, Poland.
Ewa PochećDepartment of Glycoconjugate Biochemistry, Institute of Zoology and Biomedical Research, Faculty of Biology, Jagiellonian University, Krakow, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hashimoto's thyroiditis (HT) is one of the most common organ-specific autoimmune diseases, characterized by chronic thyroid gland inflammation. Helper T (Th) CD4

Indexed as

CD4-Positive T-LymphocytesHashimoto DiseaseInterleukin-2 Receptor alpha SubunitAdultFemaleGlycosylationHumansMaleMiddle AgedPolysaccharidesIL2RA protein, humanInterleukin-2 Receptor alpha SubunitPolysaccharidesautoimmunityCD4+ T cellsglycosyltransferasesHashimoto’s thyroiditisL-thyroxineN-glycansN-glycosylation

Identifiers

PMID41030447
PMCPMC12477247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.